• Return to Headlines

Shares of ECYT Up 114.6% Since Uptrend Call on Shares

By Shiri Gupta

SmarTrend identified an Uptrend for Endocyte Inc (NASDAQ:ECYT) on February 26th, 2018 at $4.12. In approximately 2 weeks, Endocyte Inc has returned 114.58% as of today's recent price of $8.83.

Over the past year, Endocyte Inc has traded in a range of $1.17 to $9.32 and is now at $8.83, 655% above that low. Over the last five market days, the 200-day moving average (MA) has gone down 0.9% while the 50-day MA has advanced 1.1%.

Endocyte Inc. is a biopharmaceutical company developing targeted therapies for the treatment of cancer and inflammatory diseases. The Company uses a proprietary technology to create small molecule drug conjugates, SMDCs, and companion imaging diagnostics that actively target receptors that are over-expressed on diseased cells, relative to healthy cells.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Endocyte Inc shares.

Log in and add Endocyte Inc (ECYT) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights endocyte inc

Ticker(s): ECYT